Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN amyloid-β protein
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Summer BSW graduate Joseph Govreau redefines his academic journey at UMSL
After early struggles in the classroom, Govreau found academic success at UMSL and became highly involved on campus with organizations like the Student Social Work Association.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN amyloid-β protein
LATEST NEWS
- Summer BSW graduate Joseph Govreau redefines his academic journey at UMSL
- Sgt. Clayton Fair makes impact at UMSL while earning graduate certificate in accounting
- Through its humanitarian work, UMSL’s College of Optometry helps students see a new side of health care
- BSN grad Sarah Barksdale starting position at St. Louis Children’s Hospital Heart Center
- UMSL alum Angel Recci heading up St. Louis’ Telemundo station
- Sen. Kit Bond leaves behind legacy championing international education at UMSL
- Sociology graduate Sophie Heinz taking part in commencement 21 years after her father missed his opportunity because of military service
- Music education major Jake Philipak finds his passion, place at UMSL
- Double your impact: Matching gift opportunities drive Transform UMSL momentum
- New agreement opens educational, professional development opportunities for teachers and guidance counselors in The Bahamas
